ExpreS2ion to present in upcoming investor and scientific events
Hørsholm, Denmark, 18 November 2024 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor and scientific events, including the BioStock Life Science Summit, the Immunotherapies and Innovations for Infectious Diseases Congress and Aktiespararna’s Stora Aktiedagen.By attending relevant industry and investor events, the company aims to increase the awareness of its technology platform and its exciting development pipeline. More information on each event and how to register is found below and on the Company’s website (